ARAY Accuray Incorporated

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 21, 2024

ACCURAY INCORPORATED

(Exact name of registrant as specified in charter)

Delaware

(State or other jurisdiction of incorporation)

001-33301		20-8370041
(Commission File Number)		(IRS Employer Identification No.)

1240 Deming Way
Madison, Wisconsin		53717-1954
(Address of Principal Executive Offices)		(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 608 824-2800

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.001 per share		ARAY		The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

---

Item 7.01 Regulation FD Disclosure.

 

On October 21, 2024, Accuray Incorporated (the “Company”) issued a press release related to the appointment of Michael Murphy as Vice President, Corporate Controller. A copy of this press release is furnished herewith as Exhibit 99.1.

 

The information contained in this Item 7.01 disclosure, including Exhibit 99.1, is furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

 

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1 Press Release dated October 21, 2024, titled “Accuray Appoints Michael Murphy as VP, Corporate Controller”

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ACCURAY INCORPORATED
Dated: October 21, 2024	By:	/s/ Jesse Chew
		Jesse Chew
		Senior Vice President, Chief Legal Officer & Corporate Secretary

 

 

 

---

 

 

Accuray Appoints Michael Murphy as VP, Corporate Controller

 

MADISON, Wis., October 21, 2024 – Accuray Incorporated (NASDAQ: ARAY) announced today that Michael Murphy, CPA has joined the company as Vice President, Corporate Controller. Mr. Murphy will be responsible for leading the global accounting function including corporate tax, regulatory reporting, accounting policies, and risk management, along with associated budgetary and administrative operations. He will report to Accuray Senior Vice President & Chief Financial Officer Ali Pervaiz. The company also expects to appoint Mr. Murphy to the position of principal accounting officer following the filing of the company’s quarterly report on Form 10-Q for the period ended September 30, 2024.

 

Mr. Murphy brings more than 15 years of finance and accounting expertise to his new role at Accuray, most recently serving as Vice President, Chief Accounting Officer and Treasury at Duluth Holdings Inc. During his tenure with the organization, Mr. Murphy successfully led teams involved with accounting, controller and treasury functions, while introducing multiple corporate cost savings initiatives. Earlier in his career, Mr. Murphy held the roles of Chief Accounting Officer and Vice President - Assistant Controller, respectively, at financial institutions First Business Financial Services, Inc. and Banco Popular North America. He also has extensive public accounting experience having assumed positions of increasing responsibility while employed at KPMG, LLP.

 

“I couldn’t be more pleased to announce that Mike has joined the Accuray team. He is a highly experienced financial controller and accountant with a career spanning a diverse range of industries. Mike has delivered value in each role he’s held and has the business acumen required to support the achievement of our company’s revenue and profitability goals. I look forward to both his partnership and leadership in driving seamless execution that meets the strategic demands of the organization,” said Ali Pervaiz, Senior Vice President & Chief Financial Officer at Accuray.

 

“I was initially inspired and drawn to Accuray’s vision and the company’s focus on constant innovation to improve as many cancer patients’ lives as possible. As I had the opportunity to meet people throughout the organization, the value placed on collaboration and continuous improvement resonated with me. It is a culture that I am excited to be a part of,” said Michael Murphy, Vice President, Corporate Controller at Accuray.

About Accuray

Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

 

###

 

 

---

Media Contact

Beth Kaplan

Accuray

+1 (408) 789-4426

bkaplan@accuray.com

 

Investor Contact

Aman Patel, CFA

Investor Relations, ICR-Westwicke

+1 (443) 450-4191

aman.patel@westwicke.com

 

---

v3.24.3

Document and Entity Information	Oct. 21, 2024
Cover [Abstract]
Entity Registrant Name	ACCURAY INCORPORATED
Amendment Flag	false
Entity Central Index Key	0001138723
Document Type	8-K
Document Period End Date	Oct. 21, 2024
Entity Incorporation State Country Code	DE
Entity File Number	001-33301
Entity Tax Identification Number	20-8370041
Entity Address, Address Line One	1240 Deming Way
Entity Address, City or Town	Madison
Entity Address, State or Province	WI
Entity Address, Postal Zip Code	53717-1954
City Area Code	608
Local Phone Number	824-2800
Written Communications	false
Soliciting Material	false
Pre Commencement Tender Offer	false
Pre Commencement Issuer Tender Offer	false
Security 12b Title	Common Stock, par value $0.001 per share
Trading Symbol	ARAY
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

---